Trending

Pfizer has pulled its FDA request to authorise a 2-dose shot for kids under 5

Business Insider US
A boy receives a dose of the Pfizer COVID-19 vaccine at the Clalit Healthcare Services in the Israeli city of Holon near Tel Aviv on June 21.
  • Parents of kids aged 0-5 will have to wait until at least April for a vaccine.
  • Pfizer says a 3-dose regimen may provide better protection than 2 doses.
  • For more stories visit www.BusinessInsider.co.za

Pfizer announced on Friday that the company will continue to "wait for the three-dose data" from its Covid-19 vaccine trial in kids 6 months to 5 years of age, before submitting for an Emergency Use Authorisation with the US Food and Drug Administration. 

"Given that the study is advancing at a rapid pace, the companies will wait for the three-dose data as Pfizer and BioNTech continue to believe it may provide a higher level of protection in this age group," the pharmaceutical company said in a release. "The companies expect to have three-dose protection data available in early April."

The FDA's independent advisory group was set to meet next week to review the data, but that meeting will now be put on hold for at least several more weeks.

Get the best of our site emailed to you every weekday.

Go to the Business Insider front page for more stories.

Rand - Dollar
16.76
+0.3%
Rand - Pound
20.02
+0.1%
Rand - Euro
17.10
+0.0%
Rand - Aus dollar
11.42
-0.3%
Rand - Yen
0.12
+0.2%
Gold
1,746.65
+0.4%
Silver
19.39
+1.0%
Palladium
1,930.50
+0.4%
Platinum
865.50
+0.8%
Brent Crude
100.69
-2.1%
Top 40
59,703
0.0%
All Share
65,756
0.0%
Resource 10
60,483
0.0%
Industrial 25
81,441
0.0%
Financial 15
14,392
0.0%
All JSE data delayed by at least 15 minutes Iress logo